National impact on kidney failure patients decreases costs and improves outcomes
Healthcare Organization Case Study
Kidney failure patients lead to $36 billion in costs every year in the US. Poor management, infections, sepsis, and hospital readmissions are a major contributor to these costs.
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis Peer Reviewed Scientific Publication View our article in The Lancet [...]
Of the many pressing challenges posed by COVID-19, a constant has been how to treat it — and how not to. Several drugs were said to potentially increase a person’s risk of poor outcomes following [...]
Surgisphere developed a series of clinical management algorithms, supply chain recommendations, and service line advisories to help hospitals reduce HACs, readmissions, excess LOS, and cost of care. These algorithms have now been implemented at numerous hospitals throughout the United States.
Optimizing care for kidney failure patients can improve survival, decrease complications, and decrease cost per patient by $11,630 per patient per year. Secondary gains through VBP can lead to significant profit for hospital systems.
These clinical management algorithms are being implemented in hospitals throughout the United States. Successful implementation for the country of Panama helped solve a major public health crisis in 2019.